Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes

Martínez-Raga, José; Ferreros, Amparo; Knecht, Carlos; Alvaro, Raquel de; Carabal, Eloisa

doi:10.1177/2042098616679636

Cited by 30 publications

(12 citation statements)

References 105 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Additionally, classified as treatment-emergent adverse effects, standard stimulant symptoms for methylphenidates and amphetamines most often include a combination of the following: insomnia, diminished appetite, headaches, nausea, or gastrointestinal pain. [ 69 ]. The following three stimulants have also been observed to cause elevated blood pressure and elevated heart rates for patients.…”

Section: Clinical Managementmentioning

confidence: 99%

Understanding ADHD: Toward an Innovative Therapeutic Intervention

et al. 2021

View full text Add to dashboard Cite

Attention deficit hyperactivity disorder (ADHD) is a pervasive condition affecting persons across all age groups, although it is primarily diagnosed in children. This neurological condition affects behavior, learning, and social adjustment and requires specific symptomatic criteria to be fulfilled for diagnosis. ADHD may be treated with a combination of psychological or psychiatric therapeutic interventions, but it often goes unattended. People with ADHD face societal bias challenges that impact how they manage the disorder and how they view themselves. This paper summarizes the present state of understanding of this disorder, with particular attention to early diagnosis and innovative therapeutic intervention. Contemporary understanding of the mind–brain duality allows for innovative therapeutic interventions based on neurological stimulation. This paper introduces the concept of neurostimulation as a therapeutic intervention for ADHD and poses the question of the relationship between patient adherence to self-administered therapy and the aesthetic design features of the neurostimulation device. By fabricating devices that go beyond safety and efficacy to embrace the aesthetic preferences of the patient, it is proposed that there will be improvements in patient adherence to a device intended to address ADHD.

show abstract

Section: Clinical Managementmentioning

confidence: 99%

Understanding ADHD: Toward an Innovative Therapeutic Intervention

et al. 2021

View full text Add to dashboard Cite

show abstract

“…In addition to stimulant medications, nonstimulant medications (ie, atomoxetine) have been approved for the treatment of ADHD in children and adults. 26 Atomoxetine (Strattera) is believed to work by increasing the availability of norepinephrine in the intracellular space. 27 A number of studies have supported the effectiveness of atomoxetine in treating the symptoms of ADHD since it was approved in 2002.…”

Section: Nonstimulant Medicationmentioning

confidence: 99%

“…In addition to stimulant medications, nonstimulant medications (ie, atomoxetine) have been approved for the treatment of ADHD in children and adults . Atomoxetine (Strattera) is believed to work by increasing the availability of norepinephrine in the intracellular space .…”

Section: Treatment Of Attention‐deficit Hyperactivity Disordermentioning

confidence: 99%

Attention‐Deficit Hyperactivity Disorder: Clinical Considerations for Women

Marraccini¹,

Weyandt²,

Guðmundsdóttir³

et al. 2017

J Midwife Womens Health

View full text Add to dashboard Cite

Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by hyperactivity, impulsivity, and/or inattention. Women with ADHD represent a particularly vulnerable group, given their increased risk for psychosocial and parenting difficulties. Women's health care clinicians should expect to encounter women with diagnosed and undiagnosed ADHD that may or may not be treated. Pharmacologic intervention, namely, prescription stimulants, is an important consideration for pregnant and breastfeeding women with ADHD, especially because the US Food and Drug Administration has determined that there is not enough information to confirm either harm or lack of harm to the developing fetus following exposure to these drugs. Due to the increase in use of prescription stimulants without a prescription, clinicians are also likely to encounter women misusing stimulants for a variety of reasons. This article provides an overview of ADHD diagnosis, outlines effective treatment options, and offers insight into the importance for clinicians to consider prescription stimulant misuse. Guidance concerning treatment of ADHD during pregnancy and lactation is reviewed.

show abstract

“…Due to the specific cellular mechanism of action of AMP and MPH, they can be used to treat depression and anxiety as well as ADHD. In the class of non-stimulants, atomoxetine (ATX)the selective noradrenaline reuptake inhibitor, bupropion (BUP) -the norepinephrine and dopamine reuptake inhibitor and guanfacine (GNF) and clonidine (CLN) -both selective α2-adrenergic receptor agonists are used to treat ADHD [15][16][17][18][19][20][21][22][23][24]. Non-pharmacological treatment including counselling, proper diet maintenance, behavioural parenting and classroom-based interventions may also be useful for the management of ADHD [25].…”

Section: Introductionmentioning

confidence: 99%

Review on analytical methods for quantification of ADHD drugs in human biological samples

Sundari¹,

Amuthalakshmi²,

Nalini³

2020

Reviews in Analytical Chemistry

View full text Add to dashboard Cite

Attention deficit hyperactivity disorder (ADHD) is a common neuro-developmental disorder. The symptoms of ADHD include difficulty in attention, memory and impulse control. Many pharmaceutical formulations (stimulants and non-stimulants) are available on the market to treat ADHD symptoms. The most commonly used drugs for treatment are amphetamine, methylphenidate, atomoxetine, bupropion, guanfacine and clonidine. In the field of pharmaceuticals, bioanalysis is an important tool used for the quantification of drugs and their metabolites present in biological samples using various analytical methods. Although a number of analytical methods were reported for the quantification of these drugs in biological samples of experimental animals, due to species differences, it is important to develop analytical methods to quantify these drugs in human biological samples to aid forensic and pharmacokinetic studies. In this review, we compile the bio-analytical methods such as spectrophotometry, spectrofluorimetry, mass spectrometry, electrophoresis, liquid chromatography and gas chromatography used for the quantification of ADHD drugs in human biological samples such as blood, plasma, serum, oral fluids, sweat, hair and urine based on earlier published articles from various journals.

show abstract

Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes

Cited by 30 publications

References 105 publications

Understanding ADHD: Toward an Innovative Therapeutic Intervention

Understanding ADHD: Toward an Innovative Therapeutic Intervention

Attention‐Deficit Hyperactivity Disorder: Clinical Considerations for Women

Review on analytical methods for quantification of ADHD drugs in human biological samples

Contact Info

Product

Resources

About